TITLE

Control of matrix metalloproteinase production in human intestinal fibroblasts by interleukin 21

AUTHOR(S)
Monteleone, G.; Caruso, R.; Fina, D.; Peluso, I.; Gioia, V.; Stolfi, C.; Fantini, M. C.; Caprioli, F.; Tersigni, R.; Alessandroni, L.; MacDonald, T. T.; Pallone, F.
PUB. DATE
December 2006
SOURCE
Gut;Dec2006, Vol. 55 Issue 12, p1774
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: T cell-mediated immunity plays a central part in the pathogenesis of tissue damage in inflammatory bowel disease (IBD). The mechanism by which T cells mediate tissue damage during IBD remains unclear, but evidence indicates that T cell-derived cytokines stimulate fibroblasts to synthesise matrix metalloproteinases (MMPs), which then mediate mucosal degradation. We have previously shown that, in IBD, there is high production of interleukin (IL) 21, a T cell-derived cytokine, which enhances Th1 activity. Aim: To investigate whether IL21 controls MMP production by intestinal fibroblasts. Methods: IL21 receptor (IL21R) was evaluated in intestinal fibroblasts by reverse transcriptase-polymerase chain reaction (RT-PCR) and western blotting. Fibroblasts were stimulated with IL21 and MMPs were evaluated by RT-PCR and western blotting. The effect of a neutralising IL21R fusion protein (IL21R/Fc) on the induction of MMPs in fibroblosts stimulated with IBD lamina propria mononuclear cell (LPMC} supernatants was also evaluated. Results: Intestinal fibroblasts constitutively express both IL21R and the common γ chain receptor, which are necessary for IL21-driven signalling. IL21 enhances fibroblast production of MMP-1, MMP-2, MMP-3 and MMP-9, but not tissue inhibitors of MMP-1 and MMP-2. Moreover, IL21 synergises with tumour necrosis factor c to increase synthesis of MMP synthesis. IL21 enhances MMP secretion without affecting gene transcription and protein synthesis. IBD LPMC supernatants stimulate MMP secretion by intestinal fibroblasts, and this effect is partly inhibited by IL21R/Fc. Conclusions: These results suggest that fibroblasts are a potential target of IL21 in the gut and that IL21 controls MMP secretion by fibroblasts.
ACCESSION #
23512274

 

Related Articles

  • The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation. Meylan, F.; Song, Y.-J.; Fuss, I.; Villarreal, S.; Kahle, E.; Malm, I.-J.; Acharya, K.; Ramos, H. L.; Lo, L.; Mentink-Kane, M. M.; Wynn, T. A.; Migone, T.-S.; Strober, W.; Siegel, R. M. // Mucosal Immunology (1933-0219);Mar2011, Vol. 4 Issue 2, p172 

    The tumor necrosis factor (TNF)-family cytokine TL1A (TNFSF15) costimulates T cells through its receptor DR3 (TNFRSF25) and is required for autoimmune pathology driven by diverse T-cell subsets. TL1A has been linked to human inflammatory bowel disease (IBD), but its pathogenic role is not known....

  • Targeting IL-23 and Th17-Cytokines in Inflammatory Bowel Diseases. De Nitto, Daniela; Sarra, Massimiliano; Cupi, Maria Laura; Pallone, Francesco; Monteleone, Giovanni // Current Pharmaceutical Design;11/28/2010, Vol. 16 Issue 33, p3656 

    No abstract available.

  • Inflammatory Bowel Disease and Mutations Affecting the Interleukin-10 Receptor. Glocker, Erik-Oliver; Kotlarz, Daniel; Boztug, Kaan; Gertz, E. Michael; Sch�ffer, Alejandro A.; Noyan, Fatih; Perro, Mario; Diestelhorst, Jana; Allroth, Anna; Murugan, Dhaarini; H�tscher, Nadine; Pfeifer, Dietmar; Sykora, Karl-Walter; Sauer, Martin; Kreipe, Hans; Lacher, Martin; Nustede, Rainer; Woellner, Cristina; Baumann, Ulrich; Salzer, Ulrich // New England Journal of Medicine;11/19/2009, Vol. 361 Issue 21, p2033 

    Background: The molecular cause of inflammatory bowel disease is largely unknown. Methods: We performed genetic-linkage analysis and candidate-gene sequencing on samples from two unrelated consanguineous families with children who were affected by early-onset inflammatory bowel disease. We...

  • Sustained TL1A expression modulates effector and regulatory T-cell responses and drives intestinal goblet cell hyperplasia. Taraban, V. Y.; Slebioda, T. J.; Willoughby, J. E.; Buchan, S. L.; James, S.; Sheth, B.; Smyth, N. R.; Thomas, G. J.; Wang, E. C. Y.; Al-Shamkhani, A. // Mucosal Immunology (1933-0219);Mar2011, Vol. 4 Issue 2, p186 

    The tumor necrosis factor (TNF) superfamily protein TNF-like 1A (TL1A) is the ligand for death receptor 3 (DR3). TL1A is induced on activated dendritic cells (DCs) and its expression has been linked to human inflammatory bowel disease. To address how TL1A might influence intestinal inflammation,...

  • Tolerance: The dual mucus defence. Papatriantafyllou, Maria // Nature Reviews Immunology;Nov2013, Vol. 13 Issue 11, p774 

    The article offers the author's insight on the study which found that the mucus component mucin 2 (MUC2) prevents inflammation of dendritic cells (DCs) in the intestine by forming a barrier against the passage of bacteria and food antigens. She states that the presence of MUC2 reduced the...

  • Bone marrow Th17 TNFa cells induce osteoclast differentiation and link bone destruction to IBD. Syrbe, Uta; Siegmund, Britta // Gut;Jul2015, Vol. 64 Issue 7, p1011 

    The article focuses on a study conducted by the authors related to the role of T helper 17 Tumor necrosis factor-α cells in inducing osteoclast differentiation and bone destruction in inflammatory bowel diseases (IBD). It mentions that interleukin and tumor necrosis produced during of the...

  • Distinct Roles for CXCR6+ and CXCR6− CD4+ T Cells in the Pathogenesis of Chronic Colitis. Mandai, Yasushi; Takahashi, Daisuke; Hase, Koji; Obata, Yuuki; Furusawa, Yukihiro; Ebisawa, Masashi; Nakagawa, Tomoo; Sato, Toru; Katsuno, Tatsuro; Saito, Yasushi; Shimaoka, Takeshi; Yokosuka, Osamu; Yokote, Kotaro; Ohno, Hiroshi // PLoS ONE;Jun2013, Vol. 8 Issue 6, p1 

    CD4+ T cells play a central role in the development of inflammatory bowel disease (IBD) via high-level production of effector cytokines such as IFN-γ and TNF-α. To better characterize the colitogenic CD4+ T cells, we examined their expression of CXCR6, a chemokine receptor that is...

  • Induction of major histocompatibility complex class II antigens on human colonic epithelium by interferon-gamma, tumor necrosis factor-alpha, and interleukin-2. Horie, Yasuo; Chiba, Mitsuro; Suzuki, Toshio; Kudo, Takashi; Kamata, Atsushi; Iizuka, Masahiro; Masamune, Osamu // Journal of Gastroenterology;1998, Vol. 33 Issue 1, p39 

    Abstract: Class II antigens are strongly expressed on the inflamed colonic epithelium in inflammatory bowel disease. However, the mechanism of this epithelial class II antigen induction is not fully understood. Increased activities of interferon (IFN)gamma, tumor necrosis factor (TNF)alpha, and...

  • Proteases and the gut barrier. Biancheri, Paolo; Sabatino, Antonio; Corazza, Gino; MacDonald, Thomas // Cell & Tissue Research;Feb2013, Vol. 351 Issue 2, p269 

    Serine proteases, cysteine proteases, aspartic proteases and matrix metalloproteinases play an essential role in extracellular matrix remodeling and turnover through their proteolytic action on collagens, proteoglycans, fibronectin, elastin and laminin. Proteases can also act on chemokines,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics